for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Breakingviews

Breakingviews TV: Flabby activism

Posted

Starboard has produced a 197-page deck to support its opposition to Bristol-Myers’ $74 bln offer for Celgene. Antony Currie and Rob Cyran highlight the presentation’s contradictions and misplaced micromanagement that undermine Starboard’s case.

Breakingviews

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up